Clinical Trial Update: Genetically-informed Therapies for Patients With Metastatic Cancer [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating genetically-informed therapies for metastatic cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Metastatic Cancer | Phase 4 | Status: WITHDRAWN